WTO Patent Declaration Supports Incentives For Rx Companies
Executive Summary
The World Trade Organization declaration on pharmaceutical patents includes language encouraging developed countries to provide incentives to industry to improve public health in developing nations
You may also be interested in...
Rx Response To Global HIV Must Be Stronger To Save IP System – Kessler
Pharmaceutical manufacturers need to do more than rely on President Bush's global AIDS relief initiative if they want to protect the international patent system, former FDA commissioner David Kessler says
Rx Response To Global HIV Must Be Stronger To Save IP System – Kessler
Pharmaceutical manufacturers need to do more than rely on President Bush's global AIDS relief initiative if they want to protect the international patent system, former FDA commissioner David Kessler says
TRIPS Council Compulsory Licensing Report Will Be Rx Focus Post-Doha
The brandname pharmaceutical industry is focusing on a TRIPS Council report on local drug production capability in developing countries as the next key event in the interpretation of the compulsory licensing provisions in the World Trade Organization's Trade Related Aspects of Intellectual Property Rights agreement